Associated Papers
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › M121224
Fcγ receptors: genetic variation, function, and disease.
Hargreaves CE et al.
Immunological Reviews, 2015
Select a paper to view details